FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077657002> ?p ?o ?g. }

• W2077657002 endingPage "89" @default.
• W2077657002 startingPage "81" @default.
• W2077657002 abstract "Aims: Apolipoprotein C-III (apoC-III) has been recognized as a useful marker of triglyceride-rich lipoproteins (TRLs) metabolism and proposed as an indicator of prognosis for coronary risk in healthy subjects. We studied cross-sectionally in a population having low cholesterol levels, but a high prevalence of the metabolic syndrome, whether serum levels of total apoC-III or its sub-fractions were independent markers of prevalent coronary heart disease (CHD) or were related to variables reflecting the metabolic syndrome. Methods and results: In 857 unselected participants of the representative population sample of the Turkish Adult Risk Factor Survey in 2001, apoC-III as well as other risk variables were evaluated, and CHD was diagnosed based on clinical findings and Minnesota coding of resting electrocardiograms. The sample consisted of men and women, aged 33–82 years, having a mean waist circumference of 89.4 and 92.9 cm, respectively, 42% of whom had the metabolic syndrome identified by criteria of the ATP III. ApoC-III values were measured by turbidimetric immunoassay. Mean concentrations for non-high-density lipoprotein (nonHDL) apoC-III in men and women were 6.4 and 6.2 mg/dl, respectively, and for apoC-III in HDL were 6.2 and 6.3 mg/dl, respectively. NonHDL apoC-III was similar to, and apoC-III in HDL was higher than that in Western populations. Both fractions of apoC-III were significantly correlated with lipids, lipoproteins, apoB, anthropometric measures, and blood pressures in both genders. Correlations for both were high with serum triglycerides (rs=around 0.70) and apoB (rp=around 0.37). Total apoC-III as well as both fractions were significantly correlated in women also with levels of inflammatory risk markers: strongly (r=0.40–0.45, P<0.001) with complement C3, and weakly (rs=around 0.20, P<0.001) with C-reactive protein. A cutoff of >7.0 mg/dl as opposed to lower levels of nonHDL apoC-III indicated the presence of hypertriglyceridemic hyperapo B with an age-adjusted odds ratio (OR) of 13.8; it indicated the presence of metabolic syndrome with 4.66-fold likelihood. Total apoC-III and nonHDL apoC-III proved to be significantly (P-trend <0.05 and 0.002) and strongly associated with prevalent CHD in men even after adjustment for age, low-density lipoprotein-cholesterol (LDL-C) and high-density lipoprotein-cholesterol (HDL-C): OR gradients across upper and lower quartiles were 3.88-fold (CI: 1.3; 11.4) and 8.8-fold (CI: 2.6; 29.8), respectively. Conclusions: In a population among whom the metabolic syndrome prevails, total- and nonHDL apoC-III are each a determinant in both genders of the metabolic syndrome and of hypertriglyceridemic hyperapo B. Each is a powerful significant marker of prevalent CHD in men independent of LDL- and HDL-C levels. In women, despite being correlated with inflammatory risk markers, the significant association of elevated levels of apoC-III with CHD did not prove to be independent of age." @default.
• W2077657002 created "2016-06-24" @default.
• W2077657002 creator A5004225220 @default.
• W2077657002 creator A5021746678 @default.
• W2077657002 creator A5037488021 @default.
• W2077657002 creator A5044226345 @default.
• W2077657002 creator A5046124958 @default.
• W2077657002 creator A5055795450 @default.
• W2077657002 creator A5084858061 @default.
• W2077657002 date "2003-05-01" @default.
• W2077657002 modified "2023-10-11" @default.
• W2077657002 title "Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders" @default.
• W2077657002 cites W1900613292 @default.
• W2077657002 cites W1921210832 @default.
• W2077657002 cites W1972418826 @default.
• W2077657002 cites W1988731412 @default.
• W2077657002 cites W1991386799 @default.
• W2077657002 cites W1997090264 @default.
• W2077657002 cites W2008767146 @default.
• W2077657002 cites W2009316979 @default.
• W2077657002 cites W2010475848 @default.
• W2077657002 cites W2047589448 @default.
• W2077657002 cites W2047957470 @default.
• W2077657002 cites W2077567682 @default.
• W2077657002 cites W2078524991 @default.
• W2077657002 cites W2091380033 @default.
• W2077657002 cites W2092138949 @default.
• W2077657002 cites W2093287637 @default.
• W2077657002 cites W2108836811 @default.
• W2077657002 cites W2126416428 @default.
• W2077657002 cites W2131037449 @default.
• W2077657002 cites W2143340286 @default.
• W2077657002 cites W2150281931 @default.
• W2077657002 cites W2164468903 @default.
• W2077657002 cites W2185343095 @default.
• W2077657002 cites W2281418495 @default.
• W2077657002 cites W2337435963 @default.
• W2077657002 cites W2403507619 @default.
• W2077657002 cites W2415615490 @default.
• W2077657002 doi "https://doi.org/10.1016/s0021-9150(03)00025-x" @default.
• W2077657002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12732390" @default.
• W2077657002 hasPublicationYear "2003" @default.
• W2077657002 type Work @default.
• W2077657002 sameAs 2077657002 @default.
• W2077657002 citedByCount "130" @default.
• W2077657002 countsByYear W20776570022012 @default.
• W2077657002 countsByYear W20776570022013 @default.
• W2077657002 countsByYear W20776570022014 @default.
• W2077657002 countsByYear W20776570022015 @default.
• W2077657002 countsByYear W20776570022016 @default.
• W2077657002 countsByYear W20776570022017 @default.
• W2077657002 countsByYear W20776570022018 @default.
• W2077657002 countsByYear W20776570022019 @default.
• W2077657002 countsByYear W20776570022020 @default.
• W2077657002 countsByYear W20776570022021 @default.
• W2077657002 countsByYear W20776570022022 @default.
• W2077657002 countsByYear W20776570022023 @default.
• W2077657002 crossrefType "journal-article" @default.
• W2077657002 hasAuthorship W2077657002A5004225220 @default.
• W2077657002 hasAuthorship W2077657002A5021746678 @default.
• W2077657002 hasAuthorship W2077657002A5037488021 @default.
• W2077657002 hasAuthorship W2077657002A5044226345 @default.
• W2077657002 hasAuthorship W2077657002A5046124958 @default.
• W2077657002 hasAuthorship W2077657002A5055795450 @default.
• W2077657002 hasAuthorship W2077657002A5084858061 @default.
• W2077657002 hasConcept C126322002 @default.
• W2077657002 hasConcept C134018914 @default.
• W2077657002 hasConcept C2776193436 @default.
• W2077657002 hasConcept C2776919658 @default.
• W2077657002 hasConcept C2778163477 @default.
• W2077657002 hasConcept C2778913445 @default.
• W2077657002 hasConcept C2780072125 @default.
• W2077657002 hasConcept C2780221984 @default.
• W2077657002 hasConcept C2780541478 @default.
• W2077657002 hasConcept C2780578515 @default.
• W2077657002 hasConcept C2908647359 @default.
• W2077657002 hasConcept C50440223 @default.
• W2077657002 hasConcept C511355011 @default.
• W2077657002 hasConcept C61427482 @default.
• W2077657002 hasConcept C62746215 @default.
• W2077657002 hasConcept C71924100 @default.
• W2077657002 hasConcept C99454951 @default.
• W2077657002 hasConceptScore W2077657002C126322002 @default.
• W2077657002 hasConceptScore W2077657002C134018914 @default.
• W2077657002 hasConceptScore W2077657002C2776193436 @default.
• W2077657002 hasConceptScore W2077657002C2776919658 @default.
• W2077657002 hasConceptScore W2077657002C2778163477 @default.
• W2077657002 hasConceptScore W2077657002C2778913445 @default.
• W2077657002 hasConceptScore W2077657002C2780072125 @default.
• W2077657002 hasConceptScore W2077657002C2780221984 @default.
• W2077657002 hasConceptScore W2077657002C2780541478 @default.
• W2077657002 hasConceptScore W2077657002C2780578515 @default.
• W2077657002 hasConceptScore W2077657002C2908647359 @default.
• W2077657002 hasConceptScore W2077657002C50440223 @default.
• W2077657002 hasConceptScore W2077657002C511355011 @default.
• W2077657002 hasConceptScore W2077657002C61427482 @default.
• W2077657002 hasConceptScore W2077657002C62746215 @default.
• W2077657002 hasConceptScore W2077657002C71924100 @default.

• next